Form 4: Thermo Fisher Scientific Director Reports Acquisition of Phantom Stock Units

Director R. Alexandra Keith reports acquisition of phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Summary

• R. Alexandra Keith, a director of Thermo Fisher Scientific, filed a Form 4 on January 2, 2025, reporting a transaction that occurred on December 31, 2024.
• The transaction involved the acquisition of 60.07 phantom stock units at a price of $520.23 per unit, credited to the director's account under the Issuer's Deferred Compensation Plan for Directors.
• Following the reported transaction, the director beneficially owns 944.16 phantom stock units.
• These units are convertible into common stock on a 1-for-1 basis and are distributable as stock upon cessation of director service or a change of control.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of an insider transaction related to compensation.

Positives

• The acquisition of phantom stock units by a director signals confidence in the company's future performance.
• The Deferred Compensation Plan for Directors aligns the interests of directors with those of shareholders.

Future Outlook

The phantom stock units are distributable as stock upon cessation of director service (for any reason) or a change of control.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their alignment with shareholder interests.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates